Systeme zur Therapeutischen Plättchendepletion

EP3254713 Art B1 8. Januar 2020

Anmelder: Fenwal, Inc. 🇺🇸

Details

Veröffentlichungs-Nr.
EP3254713
Aktenzeichen
EP17174699
Anmeldetag
7. Juni 2017
Veröffentlichung
8. Januar 2020
Erteilung
8. Januar 2020
Rechtsraum
EP
IPC
A61M1/38A61M1/36A61M1/02
Offizieller Volltext

Abstract

Systems are provided for depleting platelets from blood. The system includes a multi-stage blood separation chamber in which blood is separated into red blood cells and platelet-rich plasma. The platelet-rich plasma is conveyed from a first stage of the chamber to a second stage, where it is separated into platelets and platelet-poor plasma. The platelet-poor plasma is conveyed out of the chamber while the platelets are allowed to accumulate in the second stage of the chamber. When a controller of the system has determined that the maximum chamber capacity of platelets has been accumulated in the second stage of the chamber, the platelets are conveyed out of the chamber to a waste container. The cycle of separating blood into its components, accumulating platelets in the chamber, and then flushing the platelets from the chamber is repeated until a target platelet concentration of the blood is achieved.

Anmelder

Firma
Fenwal, Inc.
Land
🇺🇸 USA
🇺🇸 Fenwal

US-amerikanisches Medizintechnikunternehmen mit Fokus auf Blutmanagement. Fenwal entwickelt Geräte und Verbrauchsmaterialien für Blutspende, Bluttrennung und Bluttransfusionstechnik.

407 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen